Medical meetings post-COVID – key lessons for pharmaEPG Health’s Allen Wellings assesses future symposia and congress models, outlining some learnings about content and reach. COVID-19 Share XMedical meetings post-COVID – key lessons for pharmahttps://pharmaphorum.com/views-and-analysis/medical-meetings-post-covid-key-lessons-for-pharma/
Are face-to-face medical meetings a thing of the past?Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception. Share XAre face-to-face medical meetings a thing of the past?https://pharmaphorum.com/views-and-analysis/are-face-to-face-medical-meetings-a-thing-of-the-past/
10 reasons why virtual collaboration and medical education will persist in the new normalWhile the effects of COVID-19 have been devastating for many industries, its positive impact on accelerating the uptake Share X10 reasons why virtual collaboration and medical education will persist in the new normalhttps://pharmaphorum.com/views-analysis-digital/why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/
What HCPs think about virtual congressesWith most of the world being in lockdown we are all looking for new ways to continue to Share XWhat HCPs think about virtual congresseshttps://pharmaphorum.com/r-d/views-analysis-r-d/what-hcps-think-about-virtual-congresses/
